| Literature DB >> 33526866 |
Mark A Baxter1,2, John Murphy3, David Cameron4,5, Judith Jordan6, Christine Crearie7, Christina Lilley5, Azmat Sadozye7, Mary Maclean7, Peter Hall4,5, Angela Phillips2, Alex Greger6, Jude Madeleine8, Russell D Petty9,10.
Abstract
Understanding the impact of the COVID-19 pandemic on systemic anticancer therapy delivery (SACT) is crucial to appreciate the short- and long-term consequences for cancer patients and plan future care. Here, we report real-time national SACT delivery data from NHS Scotland. We demonstrate an initial rapid reduction in patient attendance of 28.7% with subsequent rapid recovery following service redesign. The smallest decrease was seen in breast cancer (19.7%), which also had the most rapid recovery and the largest decrease seen in colorectal cancer (43.4%). Regional variation in the magnitude of impact on SACT delivery was observed, but nadirs occurred at the same time and the rate of recovery was similar across all regions. This recovery reflected a coordinated national approach and associated patient and clinician support structures, which facilitated the creation of COVID-19-protected areas for SACT delivery in Scottish cancer centres enabling rapid sharing of successful and innovative strategies. The data show that these actions have limited the disadvantage to cancer patients.Entities:
Year: 2021 PMID： 33526866 DOI： 10.1038/s41416-021-01262-8
Source DB: PubMed Journal: Br J Cancer ISSN： 0007-0920 Impact factor: 7.640